Latest filing published 23 May 2025 for Tandem Diabetes Care INC, €80k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +59.3%Entry US$29.64 · Close at T+365 US$47.23
- -53.7%Entry US$69.73 · Close at T+365 US$32.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peyton R. Howell: trading record in brief
Peyton R. Howell is active on both sides. The 19 sales, all at Cencora, Inc. where the title is Executive Vice President, total EUR 14,093,826, with a median of EUR 133,169; the two largest, EUR 3,931,075 on March 3, 2017 and EUR 3,929,862 on August 5, 2016, are almost identical. The 7 purchases, all at Tandem Diabetes Care Inc, where Peyton R. Howell is a director, are worth EUR 225,521, with a median of EUR 34,177. The highest, EUR 83,492, dates from May 17, 2023. Purchases make up 27% of open-market trades.
The record counts 66 filings for trades dated from August 5, 2016 to May 22, 2025, with 32 option exercises, 6 share grants and 2 filings of another kind. 2017 is by far the busiest year, with 28 filings, ahead of 2018 (18). No filing falls in the last twelve months.
19, 17 and 16 trades by Howell fall within 30 days of colleagues at Cencora, Inc., in that order, all on the same side. Names in order: Steven H. Collis, Dale Danilewitz and Tim G. Guttman.
Companies and markets linked to Peyton R. Howell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,387 shares@ US$20.6421.0% of flowCommon StockSEC:0001438133-25-000105:0
- 4,434 shares@ US$51.7355.4% of flowCommon StockSEC:0001438133-24-000126:0
- 949 shares0Common StockSEC:0001438133-23-000157:0
- 2,757 shares0Common StockSEC:0001438133-23-000106:0
- 3,000 shares@ US$30.16421.8% of flowCommon StockSEC:0001438133-23-000090:0Canonical exit: 15 Aug 2023 (T+90)
- 949 shares0Common StockSEC:0001438133-22-000183:0
- 1,653 shares0Common StockSEC:0001438133-22-000097:0
- 17 shares@ US$74.570.2% of flowCommon StockSEC:0001438133-22-000067:1Canonical exit: 4 Aug 2022 (T+90)
- 500 shares@ US$74.606.8% of flowCommon StockSEC:0001438133-22-000067:2Canonical exit: 4 Aug 2022 (T+90)
- 400 shares@ US$75.215.5% of flowCommon StockSEC:0001438133-22-000067:3Canonical exit: 4 Aug 2022 (T+90)
- 500 shares@ US$75.006.9% of flowCommon StockSEC:0001438133-22-000067:4Canonical exit: 4 Aug 2022 (T+90)
- 483 shares@ US$74.586.6% of flowCommon StockSEC:0001438133-22-000067:5Canonical exit: 4 Aug 2022 (T+90)
- 100 shares@ US$75.20971.9% of flowCommon StockSEC:0001438133-22-000067:0Canonical exit: 4 Aug 2022 (T+90)
- 948 shares0Common StockSEC:0001438133-21-000123:0
- 1,200 shares@ US$37.370.2% of flowCommon StockSEC:0001127602-18-014173:0
- 1,200 shares@ US$82.720.4% of flowCommon StockSEC:0001127602-18-014173:1
- 1,800 shares@ US$40.210.3% of flowCommon StockSEC:0001127602-18-014173:2
- 1,800 shares@ US$82.720.5% of flowCommon StockSEC:0001127602-18-014173:3
- 1,200 shares@ US$37.370.2% of flowCommon StockSEC:0001127602-18-010706:0
- 1,200 shares@ US$93.780.4% of flowCommon StockSEC:0001127602-18-010706:1
- 1,800 shares@ US$40.210.3% of flowCommon StockSEC:0001127602-18-010706:2
- 1,800 shares@ US$93.780.6% of flowCommon StockSEC:0001127602-18-010706:3
- 17,851 shares@ US$68.494.4% of flowCommon StockSEC:0001127602-18-009649:0
- 17,851 shares@ US$90.405.8% of flowCommon StockSEC:0001127602-18-009649:1
- 1,200 shares@ US$37.370.2% of flowCommon StockSEC:0001127602-18-004597:0
25 of 86 declarations
